Medtronic PLC (MDT)
79.07
-0.18
(-0.23%)
USD |
NYSE |
Apr 26, 10:51
Medtronic Free Cash Flow: 4.931B for Jan. 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| January 31, 2024 | 4.931B |
| October 31, 2023 | 4.045B |
| July 31, 2023 | 4.444B |
| April 30, 2023 | 4.58B |
| January 31, 2023 | 4.166B |
| October 31, 2022 | 4.822B |
| July 31, 2022 | 5.721B |
| April 30, 2022 | 5.978B |
| January 31, 2022 | 5.678B |
| October 31, 2021 | 5.773B |
| July 31, 2021 | 5.855B |
| April 30, 2021 | 4.885B |
| January 31, 2021 | 4.631B |
| October 31, 2020 | 4.752B |
| July 31, 2020 | 4.756B |
| April 30, 2020 | 6.021B |
| January 31, 2020 | 6.659B |
| October 31, 2019 | 6.298B |
| July 31, 2019 | 5.671B |
| April 30, 2019 | 5.873B |
| January 31, 2019 | 4.867B |
| October 31, 2018 | 4.864B |
| July 31, 2018 | 4.568B |
| April 30, 2018 | 3.616B |
| January 31, 2018 | 4.313B |
| Date | Value |
|---|---|
| October 31, 2017 | 4.322B |
| July 31, 2017 | 4.865B |
| April 30, 2017 | 5.626B |
| January 31, 2017 | 5.156B |
| October 31, 2016 | 4.947B |
| July 31, 2016 | 4.80B |
| April 30, 2016 | 4.172B |
| January 31, 2016 | 4.856B |
| October 31, 2015 | 4.967B |
| July 31, 2015 | 4.722B |
| April 30, 2015 | 4.331B |
| January 31, 2015 | 3.897B |
| October 31, 2014 | 3.753B |
| July 31, 2014 | 3.859B |
| April 30, 2014 | 4.563B |
| January 31, 2014 | 4.489B |
| October 31, 2013 | 4.293B |
| July 31, 2013 | 4.161B |
| April 30, 2013 | 4.485B |
| January 31, 2013 | 4.27B |
| October 31, 2012 | 3.983B |
| July 31, 2012 | 4.23B |
| April 30, 2012 | 3.986B |
| January 31, 2012 | 3.777B |
| October 31, 2011 | 3.83B |
Free Cash Flow Range, Past 5 Years
4.045B
Minimum
Oct 2023
6.659B
Maximum
Jan 2020
5.277B
Average
5.301B
Median
Free Cash Flow Benchmarks
| Abbott Laboratories | 5.059B |
| Boston Scientific Corp | 1.703B |
| Stryker Corp | 3.136B |
| Axonics Inc | -5.566M |
| Conmed Corp | 106.32M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 2.474B |
| Cash from Investing (Quarterly) | -707.00M |
| Cash from Financing (Quarterly) | -1.50B |
| Free Cash Flow Per Share (Quarterly) | 1.598 |
| Free Cash Flow to Equity (Quarterly) | 2.026B |
| Free Cash Flow to Firm (Quarterly) | 2.299B |
| Free Cash Flow Yield | 4.68% |